Natus Medical Incorporated
NTUS · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | 13.9% | -16.1% | -6.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 57.8% | 52.1% | 58.9% | 57.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 10.4% | 2.3% | 2.9% | 1.6% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 2.8% | -4% | -3.2% | -4.3% |
| EPS Diluted | 0.39 | -0.49 | -0.47 | -0.69 |
| % Growth | 179.6% | -4.3% | 31.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |